ACTIVE_NOT_RECRUITING

A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers

Talk to us

Conditions

Gastric CancerGastroEsophageal CancerGastroesophageal Junction Adenocarcinomanon-metastatic gastric cancerGEJ adenocarcinomaMIPGMITGMinimally Invasive Proximal GastrectomyMinimally Invasive total gastrectomy23-324Memorial Sloan Kettering Cancer Center

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Participants will a diagnosis of gastroesophageal junction (GEJ) adenocarcinoma and will have either a minimally invasive proximal gastrectomy (MIPG) or a minimally invasive total gastrectomy (MITG) as part of their routine care. Participants with complete a questionnaire 1 month before the surgical procedure and then 1, 3, 6 and 12 months after the surgical procedure.

Official Title

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

Quick Facts

Study Start:2024-01-08
Study Completion:2036-01-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06243757

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Able to speak and read English, Spanish, Japanese or Korean
  2. * Patients with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention
  3. * Age ≥ 18
  1. * Patients with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract
  2. * Patients with known narcotic dependence, with average daily dose \> 5 mg oral morphine equivalent
  3. * Subjects deemed unable to comply with study and/or follow-up procedures, at investigators' discretion
  4. * Patients who are pregnant (since are excluded from receiving standard-of-care MIPG or MITG)

Contacts and Locations

Principal Investigator

Vivian Strong, MD
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, New Jersey, 07920
United States
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, New Jersey, 07748
United States
Memorial Sloan Kettering Bergen (All protocol activities)
Montvale, New Jersey, 07645
United States
Memorial Sloan Kettering Commack (All Protocol Activities)
Commack, New York, 11725
United States
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, New York, 10604
United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065
United States
Memorial Sloan Kettering Nassau (Limited Protocol Activites)
Rockville Centre, New York, 11553
United States
MD Anderson Cancer Center (Data Analysis Only)
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Vivian Strong, MD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-08
Study Completion Date2036-01-08

Study Record Updates

Study Start Date2024-01-08
Study Completion Date2036-01-08

Terms related to this study

Keywords Provided by Researchers

  • gastric cancer
  • non-metastatic gastric cancer
  • Gastroesophageal Junction Adenocarcinoma
  • gastroesophageal cancer
  • GEJ adenocarcinoma
  • MIPG
  • MITG
  • Minimally Invasive Proximal Gastrectomy
  • Minimally Invasive total gastrectomy
  • 23-324
  • Memorial Sloan Kettering Cancer Center

Additional Relevant MeSH Terms

  • Gastric Cancer
  • GastroEsophageal Cancer
  • Gastroesophageal Junction Adenocarcinoma